Trichuriasis
📧 Sign up to get email alerts when something new happens for Trichuriasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-07FDA Approved: IVERMECTIN — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original ANDA for ivermectin, making a generic version of the product available for human use. The app…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections [Phase 3]
A Phase 3 clinical trial update indicates a study of emodepside for soil-transmitted helminth infections is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections [Phase 3]
This clinical trial update notes a Phase 3 study evaluating the efficacy and safety of Emodepside for soil-transmitted helminth infections, …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults [Phase 1]
A Phase 1 clinical trial update from George Washington University describes a controlled human infection study administering Trichuris trich…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita [Phase 2]
A Phase 2 trial compares a single dose of emodepside with a single dose of albendazole for Trichuris infection in adolescents and adults; th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases [Phase 4]
Phase 4 clinical trial comparing moxidectin versus ivermectin for mass drug administration to control onchocerciasis and other neglected tro…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC [Phase 2]
Phase 2 study evaluating the efficacy, safety, and acceptability of an ivermectin orally disintegrating tablet in preschool-aged children fo…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC [Phase 3]
Phase 3 trial evaluating the efficacy and safety of co-administered moxidectin and albendazole for soil-transmitted helminth infections has …
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of different oxfendazole doses versus a single dose of albendazole for Trichuriasis in…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Oxantel Pamoate in children with Trichuriasis due to Trichuris trichiura, with data on c…
-
EMA guidance · 2025-01-31New combination of medicines to treat parasitic worm infections
EMA issued an opinion endorsing the use of a combination of ivermectin and albendazole to treat parasitic worm infections as part of global …
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Evaluating Impact of Improved Floors on Health [NA]
A completed clinical trial by the London School of Hygiene and Tropical Medicine evaluated whether improved flooring affects health outcomes…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration [Phase 2, Phase 3]
Phase 2/3 trial comparing Moxidectin plus Albendazole versus Ivermectin plus Albendazole for helminth infections; results have been posted.
-
FDA approval · 2024-09-04FDA Approved: ALBENDAZOLE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' original application for albendazole, adding a generic version to the market.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura [Phase 3]
Phase 3 trial comparing ivermectin-albendazole combination to albendazole alone for Trichuris trichiura infection in school-aged children ha…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Efficacy and Safety of IVM/ALB Co-administration [Phase 2, Phase 3]
Phase 2/Phase 3 trial update on efficacy and safety of ivermectin/albendazole co-administration for trichuriasis, with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Efficacy and Safety of MOX/ALB Co-administration [Phase 3]
Phase 3 trial assessing the efficacy and safety of co-administered MOX and ALB for parasitic worm infections; completed with results posted …
-
FDA approval · 2021-09-20FDA Approved: VERMOX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA issued a supplemental approval for Vermox (mebendazole) by Janssen Pharmaceuticals, expanding/updates its label.
-
FDA approval · 2021-01-26FDA Approved: ALBENDAZOLE — Original Application (Dr.Reddys Laboratories Inc)
FDA has approved Dr. Reddy's Laboratories Inc for albendazole under an Original Application, confirming the generic's authorization for list…
-
FDA approval · 2021-01-22FDA Approved: ALBENDAZOLE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original application for albendazole from Novadoz Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Albendazole Dose Finding and Pharmacokinetics in Children and Adults [Phase 2]
Phase 2 trial update on albendazole dose finding and pharmacokinetics in children and adults completed with posted results.
-
FDA approval · 2016-10-19FDA Approved: VERMOX — Original Application (Janssen Pharmaceuticals, Inc.)
FDA approved VERMOX (mebendazole) in Janssen's original application; indicated for treatment of common intestinal helminth infections.
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2 [Phase 4]
Phase 4 clinical trial evaluating the efficacy of anthelmintics for soil-transmitted helminths, including Ascariasis, Trichuriasis, and Hook…
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: The Efficacy of Five Anthelmintic Regimes Against Trichuris Trichiura Infections in Schoolchildren in Jimma, Ethiopia [Phase 4]
Phase 4 clinical trial evaluated the efficacy of five anthelmintic regimens against Trichuris trichiura infection in schoolchildren in Jimma…
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: Safety and Efficacy of Drug Combinations Against Trichuris Trichiura [NA]
This Clinical Trial Update notes the completed study evaluating safety and efficacy of drug combinations against Trichuris trichiura (whipwo…